Daunorubicin and cytarabine with daunorubicin cytarabine and the MDR1 reversal agent PSC-833 in elderly patients with acute myelogenous leukemia

B Van der Holt; P Sonneveld; AK Burnett; PJM Vossebeld; B Beverloo; G Rosenkranz; M Dugan; WLJ Van Putten; Keith Wheatley; B Lowenberg

Daunorubicin and cytarabine with daunorubicin cytarabine and the MDR1 reversal agent PSC-833 in elderly patients with acute myelogenous leukemia

B Van der Holt, P Sonneveld, AK Burnett, PJM Vossebeld, B Beverloo, G Rosenkranz, M Dugan, WLJ Van Putten, Keith Wheatley, B Lowenberg

Cancer Clinical Trials Unit

Research output: Contribution to journal › Abstract

Original language	English
Pages (from-to)	11
Number of pages	1
Journal	Blood
Volume	104
Publication status	Published - 1 Jan 2004

Cite this

@article{b557a79b448c4dc98f4988983db6c743,

title = "Daunorubicin and cytarabine with daunorubicin cytarabine and the MDR1 reversal agent PSC-833 in elderly patients with acute myelogenous leukemia",

author = "{Van der Holt}, B and P Sonneveld and AK Burnett and PJM Vossebeld and B Beverloo and G Rosenkranz and M Dugan and {Van Putten}, WLJ and Keith Wheatley and B Lowenberg",

year = "2004",

month = jan,

day = "1",

language = "English",

volume = "104",

pages = "11",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Daunorubicin and cytarabine with daunorubicin cytarabine and the MDR1 reversal agent PSC-833 in elderly patients with acute myelogenous leukemia

AU - Van der Holt, B

AU - Sonneveld, P

AU - Burnett, AK

AU - Vossebeld, PJM

AU - Beverloo, B

AU - Rosenkranz, G

AU - Dugan, M

AU - Van Putten, WLJ

AU - Wheatley, Keith

AU - Lowenberg, B

PY - 2004/1/1

Y1 - 2004/1/1

M3 - Abstract

SN - 1528-0020

VL - 104

SP - 11

JO - Blood

JF - Blood

ER -